Physician profile
Subhan Tabba
NPI 1396323093
$927.22
in general payments reported to CMS, 2019-2025
8 companies · $171 in 2025
The $171 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $555 · 2024: $201 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $927.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $345.66 | 2023-2024 | Ultomiris |
| Inari Medical, INC. | $197.35 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Merck Sharp & Dohme LLC | $178.88 | 2023-2025 | Zerbaxa, Recarbrio, Dificid |
| Pfizer INC. | $83.53 | 2024-2025 | |
| La Jolla Pharmaceutical Company | $65.80 | 2023-2024 | Giapreza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.64 | 2023 | Jardiance |
| Abbvie INC. | $17.55 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $15.81 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Subhan Tabba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.